Literature DB >> 17604005

Attenuation of beta-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: role of sialic acid attachment.

Dhara A Patel1, James E Henry, Theresa A Good.   

Abstract

beta-Amyloid (Abeta) is the primary protein component of senile plaques in Alzheimer's disease and is believed to be associated with neurotoxicity in the disease. We and others have shown that Abeta binds with relatively high affinity to clustered sialic acid residues on cell surfaces and that removal of cell surface sialic acids attenuates Abeta toxicity. We have also shown that sialic acid functionalized dendrimeric polymers can act as mimics of cell surface sialic acid clusters and attenuate Abeta-induced neurotoxicity. In the current study, we prepared sialic-acid-conjugated dendrimers using a physiologically relevant attachment of the sialic acid to the dendrimeric termini, and evaluated the Abeta toxicity attenuation properties of the dendrimers. We compared performance of sialic-acid-conjugated dendrimeric polymers in which the sialic acid moieties were attached to dendrimeric termini via the anomeric hydroxyl group of the sialic acid, a physiological attachment, to polymers in which the attachment was made via the carboxylic acid group on the sialic acid, a non-physiological attachment. This work enhances our understanding of Abeta-cell surface binding and is a step towards the development of new classes of sequestering agents as therapeutics for the prevention of Abeta toxicity in AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604005      PMCID: PMC2031224          DOI: 10.1016/j.brainres.2007.05.055

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  57 in total

1.  Laminin 1 attenuates beta-amyloid peptide Abeta(1-40) neurotoxicity of cultured fetal rat cortical neurons.

Authors:  B Drouet; M Pinçon-Raymond; J Chambaz; T Pillot
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

2.  Interactions of amyloid beta-peptide (1-40) with ganglioside-containing membranes.

Authors:  K Matsuzaki; C Horikiri
Journal:  Biochemistry       Date:  1999-03-30       Impact factor: 3.162

3.  Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids.

Authors:  N A Avdulov; S V Chochina; U Igbavboa; C S Warden; A V Vassiliev; W G Wood
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

4.  Interaction between amyloid beta-protein aggregates and membranes.

Authors:  Atsuko Kakio; Yoshiaki Yano; Denshi Takai; Yukihiro Kuroda; Osamu Matsumoto; Yasunori Kozutsumi; Katsumi Matsuzaki
Journal:  J Pept Sci       Date:  2004-10       Impact factor: 1.905

5.  Hsp20, a novel alpha-crystallin, prevents Abeta fibril formation and toxicity.

Authors:  Sungmun Lee; Kenneth Carson; Allison Rice-Ficht; Theresa Good
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

6.  Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides.

Authors:  J McLaurin; T Franklin; P E Fraser; A Chakrabartty
Journal:  J Biol Chem       Date:  1998-02-20       Impact factor: 5.157

7.  Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers.

Authors:  J D Reuter; A Myc; M M Hayes; Z Gan; R Roy; D Qin; R Yin; L T Piehler; R Esfand; D A Tomalia; J R Baker
Journal:  Bioconjug Chem       Date:  1999 Mar-Apr       Impact factor: 4.774

8.  GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes.

Authors:  Masaki Wakabayashi; Takuma Okada; Yasunori Kozutsumi; Katsumi Matsuzaki
Journal:  Biochem Biophys Res Commun       Date:  2005-03-25       Impact factor: 3.575

9.  Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.

Authors:  D M Hartley; D M Walsh; C P Ye; T Diehl; S Vasquez; P M Vassilev; D B Teplow; D J Selkoe
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

10.  GM1 inhibits amyloid beta-protein-induced cytokine release.

Authors:  T Ariga; R K Yu
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more
  15 in total

1.  Exploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.

Authors:  Christopher B Cowan; Dhara A Patel; Theresa A Good
Journal:  J Theor Biol       Date:  2009-02-13       Impact factor: 2.691

2.  Glyconanoparticle aided detection of β-amyloid by magnetic resonance imaging and attenuation of β-amyloid induced cytotoxicity.

Authors:  Hovig Kouyoumdjian; David C Zhu; Mohammad H El-Dakdouki; Kelly Lorenz; Jianjun Chen; Wei Li; Xuefei Huang
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

3.  Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.

Authors:  Seyedmehdi Hossaini Nasr; Hovig Kouyoumdjian; Christiane Mallett; Sherif Ramadan; David C Zhu; Erik M Shapiro; Xuefei Huang
Journal:  Small       Date:  2017-11-14       Impact factor: 13.281

Review 4.  Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

Authors:  Javed Ahmad; Sohail Akhter; Md Rizwanullah; Mohammad Ahmed Khan; Lucie Pigeon; Richard T Addo; Nigel H Greig; Patrick Midoux; Chantal Pichon; Mohammad Amjad Kamal
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

5.  Response characteristics of the membrane integrity and physiological activities of the mutant strain Y217 under exogenous butanol stress.

Authors:  Yue Gao; Xiang Zhou; Miao-Miao Zhang; Ya-Jun Liu; Xiao-Peng Guo; Cai-Rong Lei; Wen-Jian Li; Dong Lu
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-19       Impact factor: 4.813

Review 6.  Neurodegenerative disorders and nanoformulated drug development.

Authors:  Ari Nowacek; Lisa M Kosloski; Howard E Gendelman
Journal:  Nanomedicine (Lond)       Date:  2009-07       Impact factor: 5.307

7.  Development of photocrosslinked sialic acid containing polymers for use in Abeta toxicity attenuation.

Authors:  Christopher B Cowan; Gerard L Coté; Theresa A Good
Journal:  Biomaterials       Date:  2008-06-03       Impact factor: 12.479

8.  Synthesis and Biological Evaluation of Non-Hydrolizable 1,2,3-Triazole Linked Sialic Acid Derivatives as Neuraminidase Inhibitors.

Authors:  Michel Weïwer; Chi-Chang Chen; Melissa M Kemp; Robert J Linhardt
Journal:  European J Org Chem       Date:  2009-06

Review 9.  Dendrimer advances for the central nervous system delivery of therapeutics.

Authors:  Leyuan Xu; Hao Zhang; Yue Wu
Journal:  ACS Chem Neurosci       Date:  2013-12-05       Impact factor: 4.418

Review 10.  Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.

Authors:  J A Smith; T Leonardi; B Huang; N Iraci; B Vega; S Pluchino
Journal:  Biogerontology       Date:  2014-06-28       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.